Overview
Quarantineâassociated insomnia (QAI)** is a form of acute or subâacute insomnia that arises primarily during periods of mandatory isolation, lockdown, or quarantine (e.g., during the COVIDâ19 pandemic). The abrupt change in daily routine, heightened stress, and reduced exposure to natural daylight can disrupt the bodyâs circadian rhythm, leading to difficulty falling asleep, staying asleep, or obtaining restorative sleep.
While anyone under quarantine can develop QAI, certain groups are disproportionately affected:
- Healthcare workers on shift work or night duty.
- Individuals living alone or without a stable support network.
- People with preâexisting mentalâhealth conditions (anxiety, depression, PTSD).
- Students and remote workers experiencing âworkâfromâhomeâ fatigue.
Prevalence: Largeâscale surveys during the COVIDâ19 pandemic reported that 30â45âŻ% of adults experienced new or worsening insomnia symptoms while under lockdownâŻ1. In a WHOâconducted multiâcountry study, 35âŻ% of respondents described âtrouble sleepingâ as a major concern during quarantineâŻ2.
Symptoms
Insomnia is defined by difficulty with sleep initiation, duration, consolidation, or quality that occurs at least three nights per week and causes daytime impairment. In the context of quarantine, the symptom pattern may be accentuated by environmental factors.
Core sleepârelated symptoms
- Difficulty falling asleep (sleep latency) â taking longer than 30âŻminutes to drift off.
- Frequent awakenings â waking up two or more times per night and having trouble returning to sleep.
- Early morning awakening â waking up at least 30âŻminutes before the desired time and being unable to fall back asleep.
- Nonârestorative sleep â feeling unrefreshed despite an apparently adequate sleep duration.
- Daytime fatigue â excessive sleepiness, reduced alertness, or âbrain fog.â
Associated physical and psychological symptoms
- Headache or tensionâtype pain.
- Increased heart rate or palpitations (often linked to anxiety).
- Irritability, mood swings, or feelings of hopelessness.
- Impaired concentration, memory lapses, or reduced work performance.
- Worsening of existing chronic conditions (e.g., hypertension, diabetes).
Causes and Risk Factors
Primary mechanisms
- Psychological stress â Fear of infection, financial uncertainty, and social isolation activate the hypothalamicâpituitaryâadrenal (HPA) axis, increasing cortisol levels that interfere with sleepâpromoting pathwaysâŻ3.
- Disruption of circadian rhythms â Reduced exposure to natural light, irregular meal times, and altered physical activity shift melatonin secretion, delaying sleep onset.
- Increased screen time â Blueâlight emission from phones, tablets, and computers suppresses melatonin, especially when used late at night.
- Behavioral changes â Sedentary lifestyle, naps during the day, and irregular bedtime routines create âsleep debt.â
- Substance use â Higher consumption of caffeine, alcohol, or nicotine to cope with stress further impairs sleep architecture.
Risk factors
- Female gender (studies show women report insomnia 1.5â2âŻtimes more often than men during lockdown)âŻ4.
- AgeâŻâ„âŻ60âŻyears â natural changes in sleep patterns compound quarantine stress.
- Living in highâdensity or noisy environments (e.g., shared apartments).
- History of psychiatric illness, especially anxiety disorders.
- Shift workers with rotating schedules.
- Lack of a dedicated âsleepâfriendlyâ space (dark, cool, quiet).
Diagnosis
QAI is diagnosed clinically; no specific laboratory test confirms it. The evaluation consists of a thorough history, screening questionnaires, and, when indicated, objective sleep studies.
Stepâbyâstep diagnostic approach
- Clinical interview â Duration, frequency, and pattern of sleep difficulty; impact on daytime functioning; recent quarantine timeline; associated stressors.
- Validated questionnaires
- Insomnia Severity Index (ISI) â scores â„15 suggest moderateâsevere insomnia.
- Pittsburgh Sleep Quality Index (PSQI) â global score >5 indicates poor sleep quality.
- Generalized Anxiety Disorderâ7 (GADâ7) and Patient Health Questionnaireâ9 (PHQâ9) to screen for comorbid anxiety/depression.
- Physical exam & labs â Rule out medical causes (thyroid dysfunction, anemia, chronic pain). Basic labs may include CBC, TSH, fasting glucose, and serum electrolytes.
- Polysomnography (PSG) â Reserved for cases where other sleep disorders (sleep apnea, periodic limb movement disorder) are suspected.
- Actigraphy â Wristâworn device that records movement and provides objective sleepâwake patterns; useful for home monitoring during quarantine.
Treatment Options
Management follows a steppedâcare model, beginning with nonâpharmacologic strategies and progressing to medication if needed.
1. Cognitiveâbehavioral therapy for insomnia (CBTâI)
- Firstâline treatment per American Academy of Sleep Medicine (AASM) guidelinesâŻ5.
- Components: sleep hygiene education, stimulus control, sleep restriction, relaxation training, and cognitive restructuring.
- Can be delivered via teleâhealth platforms, making it ideal during quarantine.
2. Sleep Hygiene & Lifestyle Modifications
- Consistent schedule â Go to bed and wake up at the same time daily, even on weekends.
- Light exposure â 30â60âŻmin of natural morning light; dim lights after 7âŻpm; consider blueâlightâfilter glasses.
- Physical activity â Moderate aerobic exercise 30âŻmin/day, preferably earlier than 4âŻpm.
- Screen curfew â Powerâdown electronic devices at least 60âŻmin before bedtime.
- Bedroom environment â Cool (16â19âŻÂ°C), dark, and quiet; use blackout curtains, earplugs, or whiteânoise machines.
- Limit stimulants â No caffeine after 2âŻpm; limit alcohol to â€1 drink and avoid close to bedtime.
3. Pharmacologic Therapy (ShortâTerm)
Medications are considered when CBTâI is unavailable or after 4â6 weeks of persistent insomnia.
| Medication Class | Examples | Typical Use | Key Precautions |
|---|---|---|---|
| Nonâbenzodiazepine hypnotics (Zâdrugs) | Zolpidem, Zaleplon, Eszopiclone | Shortâterm (â€4âŻweeks) for sleep initiation/maintenance | Potential nextâday sedation, rare dependence |
| Benzodiazepines | Temazepam, Lorazepam | Selected when anxiety coâexists | Higher dependence risk; avoid in elderly |
| Melatonin receptor agonist | Ramelteon | Circadianârelated insomnia | Generally wellâtolerated; inexpensive |
| Antidepressants with sedating properties | Trazodone, Doxepin (low dose) | When comorbid depression/anxiety | May cause daytime drowsiness; monitor cardiac effects |
| OTC antihistamines | Diphenhydramine, Doxylamine | Occasional use only | Anticholinergic load; tolerance develops quickly |
4. Adjunctive Therapies
- Mindâbody techniques: progressive muscle relaxation, guided imagery, mindfulness meditation (â10â15âŻmin/day).
- Complimentary options: acupuncture, yoga, aromatherapy (lavender oil) â evidence modest but generally safe.
Living with QuarantineâAssociated Insomnia
Daily Management Checklist
- Morning
- Expose yourself to sunlight within the first hour.
- Eat a balanced breakfast; avoid caffeine if youâre sensitive.
- Do 15â30âŻminutes of light exercise (stretching, brisk walk).
- Afternoon
- Take a brief âdigital sunsetâ â switch devices to night mode after 4âŻpm.
- Limit nap length to â€20âŻminutes before 3âŻpm.
- Evening
- Prepare a windâdown routine (warm shower, reading a physical book).
- Keep the bedroom for sleep only â no work laptops or TV.
- Set a consistent bedtime alarm (reverse of wakeâup alarm).
- Night
- If you canât sleep within 20â30âŻminutes, get out of bed, engage in a lowâstimulus activity (reading, breathing exercises) and return when sleepy.
- Use a âsleep diaryâ to track bedtime, wake time, awakenings, caffeine/alcohol intake, and mood.
Teleâhealth Resources
- CDCâs TeleâMental Health Toolkit â free guides for virtual CBTâI.
- Apps with evidenceâbased CBTâI modules (e.g., Sleepio, SHUTi).
- Online support groups moderated by mentalâhealth professionals.
Prevention
Proactive steps can curb the onset of QAI during future quarantine events or prolonged isolation.
- Maintain a regular routine â schedule work, meals, exercise, and leisure at consistent times.
- Prioritize daylight exposure â open curtains, sit on a balcony, or use a lightâtherapy box (10,000âŻlux, 30âŻmin each morning) if natural light is limited.
- Limit information overload â designate specific times to check news; avoid sensationalist media before bed.
- Set boundaries for remote work â create a âstopâworkingâ cue (e.g., closing laptop at a set hour).
- Screen for early signs â use brief sleep questionnaires weekly; intervene early with hygiene changes or CBTâI.
Complications
If QAI persists beyond 3âŻmonths (transitioning to chronic insomnia), the following health consequences may emerge:
- Increased risk of cardiovascular disease (hypertension, myocardial infarction)âŻ6.
- Metabolic dysregulation â weight gain, insulin resistance, typeâ2 diabetes.
- Exacerbation of mood disorders â higher rates of major depressive episodes and anxiety.
- Impaired immune function â reduced vaccine efficacy and higher susceptibility to infectionsâŻ7.
- Reduced cognitive performance â memory lapses, decreased reaction time, occupational accidents.
- Substance misuse â increased reliance on alcohol, sedatives, or illicit drugs for selfâmedication.
When to Seek Emergency Care
- Sudden onset of severe chest pain or palpitations accompanied by shortness of breath.
- Episodes of uncontrolled anxiety or panic attacks that lead to vomiting, loss of consciousness, or selfâharm thoughts.
- Acute confusion, hallucinations, or delirium.
- Signs of a medication overdose (e.g., extreme drowsiness, slowed breathing after taking sleep aids).
Sources: Mayo Clinic, CDC, NIH.
For persistent insomnia that interferes with daily life but does not meet emergency criteria, schedule an appointment with a primaryâcare physician or sleep specialist. Early intervention can prevent longâterm complications and improve overall wellâbeing.
References
- Wang C, et al. "Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China." Int J Environ Res Public Health. 2020;17(5):1729. PMID: 32243547.
- World Health Organization. "Mental health and psychosocial considerations during the COVID-19 outbreak." 2020. Link
- Mayo Clinic. "Insomnia." Updated 2023. Link
- Cleveland Clinic. "Insomnia: Symptoms, Causes, and Treatments." 2022. Link
- American Academy of Sleep Medicine. "Clinical Practice Guidelines for the Pharmacologic Treatment of Chronic Insomnia in Adults." SLEEP. 2021. PMID: 33989246.
- DubĂ© K, et al. "Insomnia and risk of cardiovascular disease." NEJM. 2019;381:741â751.
- Irwin MR. "Effects of sleep loss on inflammation and immunity." Journal of Clinical Sleep Medicine. 2013;9(4): 393â398.